Edwards Lifesciences (EW) Tax Provisions (2009 - 2026)

Edwards Lifesciences' Tax Provisions history runs 18 years deep, the most recent figure standing at $78.3 million for Q1 2026.

• In Q1 2026, Tax Provisions rose 11.38% year-over-year to $78.3 million; the TTM figure through Mar 2026 stood at $224.9 million (up 27.71% YoY), while the FY2025 annual figure was $216.9 million, up 42.6% from the prior year.
• Tax Provisions was $78.3 million for Q1 2026 at Edwards Lifesciences, up from $26.2 million in the prior quarter.
• In the past five years, Tax Provisions ranged from a high of $78.3 million in Q1 2026 to a low of $10.9 million in Q4 2022.
• Historically, Tax Provisions has averaged $47.6 million across 5 years, with a median of $52.7 million in 2023.
• The sharpest annual moves came in 2022 and 2025: Tax Provisions sank 73.41% in 2022, then surged 221.5% in 2025.
• A 5-year view of Tax Provisions shows it stood at $10.9 million in 2022, then jumped by 212.84% to $34.1 million in 2023, then soared by 32.26% to $45.1 million in 2024, then sank by 41.91% to $26.2 million in 2025, then soared by 198.85% to $78.3 million in 2026.
• The last three Tax Provisions figures came in at $78.3 million (Q1 2026), $26.2 million (Q4 2025), and $56.1 million (Q3 2025), per Business Quant data.